Although both the AMBASSADOR and CheckMate 274 trials reported a benefit in DFS, only CheckMate 274 demonstrated a positive trend in OS based on Kaplan–Meier curves, as the necessary follow-up duration to assess long-term outcomes has not yet been reached [ 26 ].
← all excerpts
The Dynamic Field of Perioperative Treatment for Localized Muscle-Invasive Bladder Cancer: A Review of the Current Research Landscape.
1
—
—